Submission Details
| 510(k) Number | K931701 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 1993 |
| Decision Date | January 27, 1994 |
| Days to Decision | 296 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K931701 is an FDA 510(k) clearance for the IMMULITE PAP, a Acid Phosphatase (prostatic), Tartrate Inhibited (Class II — Special Controls, product code JFH), submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on January 27, 1994, 296 days after receiving the submission on April 6, 1993. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1020.
| 510(k) Number | K931701 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 1993 |
| Decision Date | January 27, 1994 |
| Days to Decision | 296 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JFH — Acid Phosphatase (prostatic), Tartrate Inhibited |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1020 |